Aug 5, 2022, 09:16 by

Aug 4, 2022, 09:54 by

As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products.

Aug 4, 2022, 09:53 by

Aug 4, 2022, 09:49 by

BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.

Aug 4, 2022, 09:45 by

"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.

Aug 4, 2022, 09:45 by

Aug 4, 2022, 09:44 by

Dr. Vince Clinical Research (DVCR) today announced the addition of two key leadership roles to its Phase I research team.

Aug 4, 2022, 09:43 by

H1, the connecting force for global HCP, clinical, scientific, and research information, and Lokavant, the leading clinical trial intelligence company, today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development. As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.

Aug 4, 2022, 01:00 by User Not Found

Clinical Research News | In June, Walgreens launched its clinical trial business in an effort to combine the company’s vast foundation of patient insights, partner-enabled health and technology capabilities, and in-person and virtual care options to break through barriers to engaging broader and more diverse communities.

Aug 3, 2022, 09:47 by

BrainCheck announced an Investigator Initiated Research (IIR) Grant Program to help fund research for evaluation, diagnosis, treatment and care for brain related disease. This includes, but is not limited to, Alzheimer's disease and related dementias (ADRD), post-operative delirium, stroke, traumatic brain injury, and post-acute Covid “brain fog”. Awardees will be provided one-year research funding and free access to the BrainCheck platform.

Aug 3, 2022, 09:46 by

Creative Peptides delivers phage display services with a versatile phage peptide library, hoping to assist researchers in jumpstarting peptide drug screening.

Aug 3, 2022, 09:45 by

Upgrade to Calyx RIM on Microsoft Azure drives efficiencies and patient safety

Aug 2, 2022, 09:48 by

Jackson ImmunoResearch has announced a new addition to its range of products for scientists developing immunoassays for serology and diagnostics markets.

Aug 2, 2022, 09:48 by

PCR Biosystems has launched the Air-Dryable Probe 1-Step Mix, a versatile all-in-one, air-dryable 4X RT-qPCR reagent mix for ultra-sensitive detection of RNA and DNA sequences.

Aug 2, 2022, 09:47 by

Aug 2, 2022, 09:47 by

Aug 2, 2022, 09:47 by

Calidi Biotherapeutics, a clinical-stage biotechnology company is pleased to announce that City of Hope has received FDA authorization to proceed with a phase 1 physician-sponsored clinical trial that will deliver Calidi’s cutting-edge oncolytic virotherapy platform, NSC-CRAd-S-pk7 (NeuroNova), to patients with recurrent high-grade glioma.

Aug 2, 2022, 09:45 by

Aug 2, 2022, 09:45 by

Aug 2, 2022, 09:45 by